Episode 365
One on One Video Call W/George
https://tidycal.com/georgepmonty/60-minute-meeting
Support the show:
https://www.paypal.me/Truelifepodcast?locale.x=en_US
https://journalbipolardisorders.springeropen.com/articles/10.1186/s40345-022-00265-5
Abstract:
This is a narrative review about the role of classic and two atypical psychedelics in the treatment of unipolar and bipolar depression. Since the 1990s, psychedelics experience a renaissance in biomedical research. The so-called classic psychedelics include lysergic acid diethylamide (LSD), psilocybin, mescaline and ayahuasca. Characteristic effects like alterations in sensory perception, as well as emotion- and self-processing are induced by stimulation of serotonin 2A receptors in cortical areas. The new paradigm of psychedelic-assisted psychotherapy suggests a therapeutic framework in which a safely conducted psychedelic experience is integrated into a continuous psychotherapeutic process. First randomized, controlled trials with psilocybin show promising efficacy, tolerability, and adherence in the treatment of unipolar depression.
One on One Video call W/George
https://tidycal.com/georgepmonty/60-minute-meeting
Support the show:
https://www.paypal.me/Truelifepodcast?locale.x=en_US
🔥 Save $2,000: Master Plant Medicines from Home (Ayahuasca, Psilocybin, San Pedro & Cannabis)
Transform Your Mental Health & Consciousness with Blue Morpho’s Proven Courses:
https://bluemorpho.org/plant-medicine-training/george/?ref=george
🚨🚨Curious about the future of psychedelics? Imagine if Alan Watts started a secret society with Ram Dass and Hunter S. Thompson… now open the door.
Use Promocode TRUELIFE for Get 25% off monthly or 30% off the annual plan For the first year
The Lila Code:
https://orcid.org/0009-0008-4612-3942
Published on 2Â years, 9Â months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate